Cosmo Pharmaceuticals logo

Cosmo Pharmaceuticals

We develop innovative treatments that address significant unmet clinical needs

202 employees · est. 1997 · Dublin, Ireland

VS
Cyxone logo

Cyxone

Life-changing treatments for disorders of the immune system

11 employees · est. 2015 · Malmo, Sweden

Cosmo Pharmaceuticals is the older company (1997 vs 2015); Cosmo Pharmaceuticals is the larger of the two.

Side-by-Side Comparison

Cosmo Pharmaceuticals Cyxone
Founded
1997 older 2015
Headquarters
Dublin, Ireland Malmo, Sweden
Employees
202 larger 11
Industry
Biotechnology, Health Care, Manufacturing Biotechnology, Health Care
Funding Stage
Post Ipo Debt Not tracked yet
Total Funding
$25.00M Not tracked yet
Funding Rounds
1 Not tracked yet
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Pharmaceuticals, Specialty Drugs, Gastroenterology, Endoscopy, Clinical Development, Inflammatory Bowel Diseases, Ulcerative Colitis, Crohn's Disease, Colon Infections, Drug Manufacturing, Colonoscopy, Clinical Trials, Nutraceuticals, Medical Research, Innovative Treatments Biotech, Clinical Research, Immunomodulating Drugs, Autoimmune Diseases, Multiple Sclerosis, Rheumatoid Arthritis, Pharmaceuticals, Drug Development, Clinical Trials, Immune System Disorders, Medicine, Quality Of Life, Treatment, Therapy, Clinical Phase II Program
Website
cosmopharma.com cyxone.com
Cosmo Pharmaceuticals logo

About Cosmo Pharmaceuticals

Cosmo Pharmaceuticals Analysis: Cosmo Pharmaceuticals is a biotechnology and pharmaceutical company based in Ireland, founded in 1996. The company's slogan "We develop innovative treatments that address significant unmet clinical needs" underscores its commitment to pioneering medical solutions. Cos...

Cyxone logo

About Cyxone

Cyxone is a Swedish clinical biotech company that focuses on developing immunomodulating drugs for treating autoimmune diseases such as multiple sclerosis (MS) and rheumatoid arthritis (RA). The company's portfolio includes rabeximod, currently in a clinical phase II program for RA, and T20K, which...

We will tell you when either one moves

BounceWatch watches Cosmo Pharmaceuticals and Cyxone for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Cosmo Pharmaceuticals and Cyxone — by email.

Frequently Asked Questions

Cosmo Pharmaceuticals — We develop innovative treatments that address significant unmet clinical needs. Cyxone — Life-changing treatments for disorders of the immune system. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Cosmo Pharmaceuticals has raised $25.00M while Cyxone has raised undisclosed funding.
Cosmo Pharmaceuticals and Cyxone operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Cosmo Pharmaceuticals with someone else

Start typing a company name or domain.

Related Comparisons

Compiled from the BounceWatch company index. We last looked at Cosmo Pharmaceuticals on 12 Sep 2024, and Cyxone on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy